Rystiggo (rozanolixizumab-noli) can be safely self-administered by people with myasthenia gravis (MG), according to data from a Phase 3 clinical trial. Based on these findings, at-home administration of Rystiggo was […] The post At-home Rystiggo infusion safe; most MG patients prefer self-care appeared first on Myasthenia Gravis News.
